Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

Author:

İlgen UfukORCID,Karadağ ÖmerORCID,Emmungil HakanORCID,Küçükşahin OrhanORCID,Koca Süleyman SerdarORCID,Erden AbdülsametORCID,Bes CemalORCID,Alpay Kanıtez NilüferORCID,Dalkılıç EdizORCID,Akar ServetORCID,Mercan RıdvanORCID,Çınar MuhammetORCID,Kaşifoğlu TimuçinORCID,Gönüllü EmelORCID,Kimyon GezmişORCID,Ersözlü DuyguORCID,Atagündüz PamirORCID,Kılıç LeventORCID,Ertenli İhsanORCID,Yazısız VeliORCID,Ateş AşkınORCID,Kiraz SedatORCID,Kalyoncu UmutORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference49 articles.

1. World Health Organization (2018) Latent tuberculosis infection—Updated and consolidated guidelines for programmatic management. https://apps.who.int/iris/handle/10665/260233 Accessed 3 April 2022

2. Iannone F, Cantini F, Lapadula G (2014) Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations. J Rheumatol Suppl 91:41–46. https://doi.org/10.3899/jrheum.140101

3. Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1–26. https://doi.org/10.1002/art.39480

4. Koike R, Takeuchi T, Eguchi K, Miyasaka N, College J, of Rheumatology, (2007) Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Mod Rheumatol 17:451–458. https://doi.org/10.1007/s10165-007-0626-3

5. Australian Rheumatology Association (2018) Screening for Latent Tuberculosis Infection (LTBI) and its management in Inflammatory arthritis patients. https://rheumatology.org.au/Portals/2/Documents/Public/Professionals/SCREENINGFORLATENTTUBERCULOSISINFECTION_Jan18.pdf?ver=2021-06-28-141621-710 Accessed 3 April 2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3